MNKD Stock Analysis: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$3.91
-0.20 (-4.87%)
▼
5d:
-5.33%
30d:
-3.46%
90d:
+38.16%
HOLD
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
1d
Smart Money Accumulation
None View Scanner →
Strength: 5.8/10
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MNKD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MNKD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.25
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$6.36
38.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $3.91, which is considered slightly low relative to its 30-day fair value range of $3.89 to $4.21. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.0) compared to its historical average (24.2). Remarkably, the market is currently pricing in an annual earnings decline of 9.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNKD is in a strong uptrend. Immediate support is located at $3.71, while resistance sits at $4.24. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.72 (+97.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MNKD is in a strong uptrend. Immediate support is located at $3.71, while resistance sits at $4.24. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.72 (+97.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.89 -
$4.21
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding MNKD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 97.4% below Wall St target ($7.72)
- CAUTION: Recommendation downgraded due to -5.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.89 -
$4.21
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.71
Resistance Level
$4.24
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.98
Wall Street Target
$7.72
(+97.4%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
-34.9%
Profit Margin
-6.6%
Valuation Discount vs History
-9.4% cheaper
PE vs Historical
18.0 vs 24.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.4%
(market-implied from PE analysis)
1-Year Target
$3.54
(-9%)
2-Year Target
$3.21
(-18%)
3-Year Target
$2.91
(-26%)
3-Yr Target (if PE normalizes)
(PE: 18→24)
$3.91
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 112.2%)
$15.22
(+289%)
Base:
(SPY PE: 18.0, Growth: 112.2%)
$13.20
(+238%)
Bear:
(PE: 15.3, Growth: 112.2%)
$11.22
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.0 to 24.2
Stabilization Target:
$5.26
(+34.6%)
PE Expansion Potential:
+34.6%
Share & Embed Analysis
Last updated: August 03, 2026 2:57 AM ET
Data refreshes hourly during market hours. Next update: 3:57 AM
Data refreshes hourly during market hours. Next update: 3:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael Castagna
BUY
100000 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$33 | 58 HOLD |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
